Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China flag China · Delayed Price · Currency is CNY
42.10
+0.22 (0.53%)
Nov 17, 2026, 3:00 PM CST

SHA:688050 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
243.66268.17388.4303.98232.69171.34
Depreciation & Amortization
167.31167.31133.2176.7343.3532.04
Other Amortization
12.5112.5112.389.739.087.33
Loss (Gain) From Sale of Assets
0.090.09-0.02-0.11-0.01-0.02
Asset Writedown & Restructuring Costs
72.1572.152.08---
Loss (Gain) From Sale of Investments
-4.81-4.810.69-11.7-18.58-19.59
Provision & Write-off of Bad Debts
11.2211.2210.99.138.375.74
Other Operating Activities
-22.4810.6522.72-9.64-3.07-1.91
Change in Accounts Receivable
-129.39-129.39-127.09-103.52-45.761.12
Change in Inventory
-72.53-72.53-86.09-85.12-22.823.35
Change in Accounts Payable
50.9250.927.1521.4621.4115.07
Change in Other Net Operating Assets
2.022.026.1112.3917.5613.25
Operating Cash Flow
311.5369.15347.75212.62250.13219.3
Operating Cash Flow Growth
-13.66%6.15%63.56%-15.00%14.06%77.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-166.71-123.14-329.48-370.34-271.03-311.22
Sale of Property, Plant & Equipment
2.020.030.010.430.04-
Cash Acquisitions
-672.28-30.33-72.3-47.03--
Divestitures
-2.3----
Investment in Securities
-27.75-2.58-213.06439.64-51.29-120.9
Other Investing Activities
32.289.751.0615.9721.4419.75
Investing Cash Flow
-832.44-143.96-613.7632.67-307.84-420.37

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-35481.6212.1610143.37
Long-Term Debt Repaid
--65-299.86-19.43-5.4-
Lease Payments
-7.24-7.24-6.22-5.35-1.8-
Net Debt Issued (Repaid)
526.2-30181.75-7.274.6143.37
Issuance of Common Stock
0.76287.713.9713.481.5624.91
Repurchase of Common Stock
---20.04---
Common Dividends Paid
-90.49-89.46-70.56-61.37-44.44-30.52
Other Financing Activities
-20.57-125.672.99-8.41-26.79-0.02
Financing Cash Flow
415.8942.5898.12-63.57-65.07137.74

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.48-1.86-0.020.04-0.04-0.64
Net Cash Flow
-109.52265.91-167.91181.76-122.82-63.97

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
144.79246.0118.27-157.72-20.9-91.92
Free Cash Flow Growth
-32.81%1246.45%----
Free Cash Flow Margin
8.09%16.59%1.30%-16.58%-3.61%-21.22%
Free Cash Flow Per Share
0.751.280.10-0.83-0.11-0.49
Levered Free Cash Flow
-90.3393-182.75-215.88-110.16-105.6
Unlevered Free Cash Flow
-71.04107.37-169.8-209.74-108.89-105.14
Free Cash Flow After Leases
137.55238.7712.05-163.08-22.7-91.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
182.17161.48157.99157.9358.7557.3
Change in Working Capital
-168.15-168.15-222.61-165.5-21.7124.36